🔗 Share this article

An underground economy for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.

Active Trade on Messaging Platforms

Separately, a robust trade exists on messaging services, where groups with thousands of participants share comparison photos, administration instructions and assertions of next-day UK delivery. Vendors promote the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have warned that the sale of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering substances of uncertain source.

Some professionals said the popularity for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Marketing retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved medication that must not be marketed or supplied for human use under the British medical regulations.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, prosecution or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the platform has removed problematic content and banned associated hashtags and search suggestions. The company stated it was committed to maintaining the service secure and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also discovered groups with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with thousands of members, filled with images of slimming results, positive reviews and step-by-step instructions for preparing or injecting at residence.

Within minutes of entering one community, a seller shared contact information, where the majority of transactions take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. Not one asked about weight, health issues or past usage.

Item Details and Costs

Within these groups, posts show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use pens usually sold at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for Telegram said it actively monitored harmful material on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they can’t verify. Even if the science behind retatrutide is sound, these digital versions may not include what they claim,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs rising, patients are using social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she explained.

Her team has previously seen individuals injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational substance not yet authorized … may subject users to potentially significant medical dangers”.